Holy Stone Healthcare Co., Ltd. (TPEX:4194)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
7.04
+0.32 (4.76%)
Mar 24, 2026, 1:55 PM CST
Market Cap1.03B -31.3%
Revenue (ttm)n/a
Net Income-111.35M
EPS-0.76
Shares Out145.97M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume40,558
Average Volume70,207
Open7.00
Previous Close6.72
Day's Range6.80 - 7.32
52-Week Range5.32 - 12.65
Beta0.73
RSI43.89
Earnings DateMar 26, 2026

About Holy Stone Healthcare

Holy Stone Healthcare Co., Ltd. develops and sells hyaluronic acid-related therapeutic products in Taiwan. The company offers RenehaVis, a product designed to relive pain and stiffness of the knee joint; SportVis, a treatment to relive the pain and optimize the recovery of tendon and ligament injuries; TRUD, a treatment that allows mucosal tissue to heal naturally and reduces the symptoms of ulcerative colitis; and GAF, a treatment for anal mucosal lesions. It is also developing IBD98-M, which is in Phase II a clinical trials for the treatment ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4194
Full Company Profile

Financial Performance

Financial Statements